Closed · RFA-FD-11-017 · CFDA 93.103 · Discretionary
Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01)
Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.
- $250K-$350K
- Award range
- Closed
- Status
- June 16, 2011
- Close date
- 20
- Expected awards
The verdict
Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01) is a closed discretionary listing from Food and Drug Administration that offered $250,000 -- $350,000 across 20 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 481 other opportunities from Food and Drug Administration.
- $250K-$350K
- award range
- Closed
- application status
- 20
- expected awards
- 93.103
- CFDA program
Archived opportunity record
Innovation in Development and Qualification o… is closed (last close June 16, 2011). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed June 16, 2011
Est. Total Funding
$1,000,000
Expected Awards
20
Instrument
Cooperative Agreement
Description
As part of Food and Drug Administration's Advancing Regulatory Science initiative the Office of Critical Path Programs (OCPP) supports innovation to improve the development and evaluation of new safe and effective medical products for diagnosing, treating, and preventing conditions and diseases. OCPP is working to harness new science and new technologies to further this goal.This Funding Opportunity Announcement (FOA) will provide resources for research into the development and qualification of alternative methodologies in the area of reproductive toxicology, which have the potential to be more predictive than the currently required testing, and which will reduce, refine, or replace animal testing.Applications should address the Critical Path Initiative's mission to facilitate the development of new safe and effective products for diagnosing, treating, and preventing disease.
Campus–civic applicant bridge · 2 doors
Innovation in Development and Qualification o… bridges educational institutions with civic applicant types (2 doors: Nonprofits with 501(c)(3) status (other than IHEs); Private institutions of higher education). Expect campus and public/nonprofit operators in the same printed set. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Health · Science and Technology / R&D (HL;ST). Only 1 other Food and Drug Administration listing share this exact eligibility-code string (0% of 482).
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Food and Drug Administration Research
U.S. Department of Health and Human Services
Agency Contact
Gladys M. Bohler Grants Management Officer/Specialist Phone 301-827-7175
More from Food and Drug Administration
Federal and University Partnership to Improve the Safety of Seafood from the Gulf of America
Research, Education, and Outreach on Botanical Natural Products
Cooperative Agreement to Support Shellfish Safety Assistance Project
Education and Outreach to Tribal Producers through the Tribal Food Safety Alliance
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
What to do next
Innovation in Development and Qualification o… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.103 may publish future NOFOs under the same assistance listing. Open program
- Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
- Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |